Technical Analysis for ABEO - Abeona Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 5.75 | -2.38% | -0.14 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -2.38% | |
| Calm After Storm | Range Contraction | -2.38% | |
| NR7 | Range Contraction | -2.38% | |
| Lower Bollinger Band Walk | Weakness | -2.38% |
| Alert | Time |
|---|---|
| Down 3% | about 18 hours ago |
| Fell Below 200 DMA | about 18 hours ago |
| Lower Bollinger Band Support | about 20 hours ago |
| 200 DMA Support | about 21 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/11/2024
Abeona Therapeutics Inc. Description
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Genetics Genetic Engineering Anemia CRISPR Genome Editing Adeno Associated Virus Cas9 Severe And Rare Diseases Blood Diseases Fanconi Anemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.01 |
| 52 Week Low | 3.05 |
| Average Volume | 279,597 |
| 200-Day Moving Average | 5.76 |
| 50-Day Moving Average | 6.19 |
| 20-Day Moving Average | 6.20 |
| 10-Day Moving Average | 6.07 |
| Average True Range | 0.30 |
| RSI (14) | 36.31 |
| ADX | 15.74 |
| +DI | 13.92 |
| -DI | 20.88 |
| Chandelier Exit (Long, 3 ATRs) | 5.87 |
| Chandelier Exit (Short, 3 ATRs) | 6.54 |
| Upper Bollinger Bands | 6.68 |
| Lower Bollinger Band | 5.73 |
| Percent B (%b) | 0.02 |
| BandWidth | 15.30 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.071 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.31 | ||||
| Resistance 3 (R3) | 6.33 | 6.17 | 6.21 | ||
| Resistance 2 (R2) | 6.17 | 6.03 | 6.16 | 6.18 | |
| Resistance 1 (R1) | 5.96 | 5.94 | 5.88 | 5.94 | 6.15 |
| Pivot Point | 5.80 | 5.80 | 5.76 | 5.79 | 5.80 |
| Support 1 (S1) | 5.59 | 5.66 | 5.51 | 5.57 | 5.35 |
| Support 2 (S2) | 5.43 | 5.57 | 5.42 | 5.32 | |
| Support 3 (S3) | 5.22 | 5.43 | 5.29 | ||
| Support 4 (S4) | 5.20 |
